Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (35)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Boyle, P.
Right arrow Articles by Leon, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boyle, P.
Right arrow Articles by Leon, M. E.
Related Collections
Right arrow Oncology
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Medical Bulletin 64:1-25 (2002)
© 2002 The British Council

Epidemiology of colorectal cancer

Peter Boyle and Maria Elena Leon

Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy

Colorectal cancer is a important public health problem: there are nearly one million new cases of colorectal cancer diagnosed world-wide each year and half a million deaths. Recent reports show that, in the US, it was the most frequent form of cancer among persons aged 75 years and older. Given that the majority of cancers occur in elder people and with the ageing of the population in mind, this observation gives further impetus to investigating prevention and treatment strategies among this subgroup of the population. Screening research, recommendations and implementation is an obvious priority.

While there are many questions to be resolved, it is apparent that many facets of colorectal cancer are becoming increasingly understood and prospects for prevention are becoming apparent. Achieving colorectal cancer control is the immediate challenge.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 GutHome page
S Le Gouvello, S Bastuji-Garin, N Aloulou, H Mansour, M-T Chaumette, F Berrehar, A Seikour, A Charachon, M Karoui, K Leroy, et al.
High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas
Gut, June 1, 2008; 57(6): 772 - 779.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
B. Gruenberger, D. Tamandl, J. Schueller, W. Scheithauer, C. Zielinski, F. Herbst, and T. Gruenberger
Bevacizumab, Capecitabine, and Oxaliplatin As Neoadjuvant Therapy for Patients With Potentially Curable Metastatic Colorectal Cancer
J. Clin. Oncol., April 10, 2008; 26(11): 1830 - 1835.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
G. Folprecht, M. T. Seymour, L. Saltz, J.-Y. Douillard, H. Hecker, R. J. Stephens, T. S. Maughan, E. Van Cutsem, P. Rougier, E. Mitry, et al.
Irinotecan/Fluorouracil Combination in First-Line Therapy of Older and Younger Patients With Metastatic Colorectal Cancer: Combined Analysis of 2,691 Patients in Randomized Controlled Trials
J. Clin. Oncol., March 20, 2008; 26(9): 1443 - 1451.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
D. Z. J. Chu, G. Gibson, D. David, and Y. Yen
The Surgeon's Role in Cancer Prevention. The Model in Colorectal Carcinoma
Ann. Surg. Oncol., November 1, 2007; 14(11): 3054 - 3069.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
P. L. Mai, J. Sullivan-Halley, G. Ursin, D. O. Stram, D. Deapen, D. Villaluna, P. L. Horn-Ross, C. A. Clarke, P. Reynolds, R. K. Ross, et al.
Physical Activity and Colon Cancer Risk among Women in the California Teachers Study
Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 517 - 525.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. I. Neugut, M. Matasar, X. Wang, R. McBride, J. S. Jacobson, W.-Y. Tsai, V. R. Grann, and D. L. Hershman
Duration of Adjuvant Chemotherapy for Colon Cancer and Survival Among the Elderly
J. Clin. Oncol., May 20, 2006; 24(15): 2368 - 2375.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
W. C. Taylor
A 71-Year-Old Woman Contemplating a Screening Colonoscopy
JAMA, March 8, 2006; 295(10): 1161 - 1167.
[Full Text] [PDF]

Home page
 Br. J. Radiol.Home page
V L Jardine, E Sala, and D J Lomas
MR colonography: baseline appearance of the unprepared rectosigmoid
Br. J. Radiol., March 1, 2005; 78(927): 202 - 206.
[Abstract] [Full Text] [PDF]

Home page
 Psychosom. Med.Home page
M. Kojima, K. Wakai, S. Tokudome, K. Tamakoshi, H. Toyoshima, Y. Watanabe, N. Hayakawa, K. Suzuki, S. Hashimoto, M. Kawado, et al.
Perceived Psychologic Stress and Colorectal Cancer Mortality: Findings From the Japan Collaborative Cohort Study
Psychosom Med, January 1, 2005; 67(1): 72 - 77.
[Abstract] [Full Text] [PDF]

Home page
 Health Education JournalHome page
K.J. Dyer, K C H Fearon, K. Buckner, and R.A. Richardson
Diet and colorectal cancer risk: Baseline dietary knowledge of colorectal patients
Health Education Journal, January 1, 2004; 63(3): 242 - 253.
[Abstract] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
J. S. Mandel
Sigmoidoscopy Screening Probably Works, but How Well Is Still Unknown
J Natl Cancer Inst, April 16, 2003; 95(8): 571 - 573.
[Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.